1 |
Uematsu H, Sadato N, Yonekura Y, et al: Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG. J Nucl Med 1998;39(12):2121-2127
|
2 |
Block MI, Patterson GA, Sundaresan RS, et al: Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-777
DOI
ScienceOn
|
3 |
Townsend DW, Beyer T, Kinahan PE, et al: Recent studies with a combined PET/CT scanner. International Congress Series, 24th-26th September 1999, Hokkaido, Japan. Amsterdam: Elsevier Science B.V. p 229-244
|
4 |
Hawighorst H, Knapstein PG, Weikel W, et al: Invasive cervix carcinoma( pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resornance image(MRI) in comparison with extensive cross section and histopathologic findings. Radiologe 1997;37:130-138
DOI
ScienceOn
|
5 |
Smith TA: FDG uptake, tumor characteristics and response to therapy: a review. Nucl Med Commun 1998;19(2):69-82
|
6 |
Shreve PD, Anzai Y, Wahl RL: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19(1):61-77;quiz 150-151
DOI
|
7 |
Vansteenkiste JF, Stroobants SG, Dupont PJ, et al: FDG-PET scan in potentially operable non-small lung cancer: do anatometabolic PETCT fusion images improve the localization of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25(11):1495-1501
DOI
|
8 |
Dwamena BA, Sonnad SS, Angobaldo JO, et al: Metastases from non-small cell lung cancer. Mediastinal staging in the 1990s. Metaanalytic comparison of PET and CT. Radiology 1999;213:530-536
DOI
|
9 |
I. Frank Ciernik, Elena Dizendorf, Brigitta G, et al: Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasiblity study. Int J Radiation Oncology Biol Phys 2003;57:853-863
DOI
ScienceOn
|
10 |
Maier AG, Kersting-Sommerhoff B, Reeders JW, et al: Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamde injection. Results of a multicenter phase II trial. J Magn Reson Imaging 2000;12:651-660
DOI
ScienceOn
|
11 |
Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK: Whole-body PET:physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37(3):441-446
|
12 |
Czernin J, Phelps ME: Positron emission tomography scanning. Current and future applications. Ann Rev Med 2002;53:89-112
DOI
ScienceOn
|
13 |
Gupta NC, Tamim WJ, Graeber GG, et al: Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521- 527
DOI
ScienceOn
|
14 |
Paul G, Kluetz, Carolyn Cidis Meltzer, et al: Combined PET/CT Imaging in Oncology: Impact on Patient Management. Clinical Positron Imaging 2000;3:223-230
DOI
ScienceOn
|